CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...
Phase 3
Nashville, Tennessee, United States and 217 other locations
The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of spe...
Brentwood, Tennessee, United States and 1 other location
This study is an adaptive, randomized, double blind, platform trial evaluating promising investigational products (IP) for safety and efficacy as ear...
Phase 2
Nashville, Tennessee, United States and 5 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Nashville, Tennessee, United States and 66 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Nashville, Tennessee, United States and 114 other locations
This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...
Phase 2, Phase 3
Nashville, Tennessee, United States and 94 other locations
doses of IgPro20 in participants with post SARS-CoV-2 infection 2019 postural orthostatic tachycardia syndrome (post-Coronavirus Disease 2019 \[COVID...
Phase 3
Nashville, Tennessee, United States and 27 other locations
The study is divided into 2 parts: Part 1 and Part 2. The purpose of Part 1 of this study is to generate sufficient safety, reactogenicity, and immun...
Phase 1, Phase 2
Hendersonville, Tennessee, United States and 68 other locations
This study will (1) recruit, train and provide resources to approximately 30 Emergency Department (ED) sites throughout the U.S. using implementation...
Phase 2
Nashville, Tennessee, United States and 34 other locations
treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...
Phase 3
Nashville, Tennessee, United States and 431 other locations
Clinical trials
Research sites
Resources
Legal